Ilias Lagkouvardos1,2, Karoline Kläring1, Silke S Heinzmann3, Stefanie Platz4, Birgit Scholz5, Karl-Heinz Engel5, Philippe Schmitt-Kopplin3,6, Dirk Haller2, Sascha Rohn4, Thomas Skurk7, Thomas Clavel1. 1. Research Group Intestinal Microbiome, ZIEL Institute for Food and Health, Technische Universität München, Freising, Germany. 2. Chair of Nutrition and Immunology, Technische Universität München, Freising, Germany. 3. Analytical BioGeoChemistry, Helmholtz Zentrum München, Neuherberg, Freising, Germany. 4. Food Chemistry, Hamburg University, Hamburg, Germany. 5. General Food Technology, Technische Universität München, Freising, Germany. 6. Chair of Analytical Food Chemistry, Technische Universität München, Freising, Germany. 7. ZIEL Human Study Unit, Technische Universität München, Freising, Germany.
Abstract
SCOPE: Flaxseeds contain the phytoestrogens lignans that must be activated to enterolignans by intestinal bacteria. We investigated the impact of flaxseeds on fecal bacterial communities and their associations with fecal and blood metabolites. METHODS AND RESULTS: Nine healthy male adult subjects ingested 0.3 g/kg/day flaxseeds during 1 week. Gut bacteria as well as blood and fecal metabolites were analyzed. Ingestion of flaxseeds triggered a significant increase in the blood concentration of enterolignans, accompanied by fecal excretion of propionate and glycerol. Overall diversity and composition of dominant fecal bacteria remained individual specific throughout the study. Enterolactone production was linked to the abundance of two molecular species identified as Ruminococcus bromii and Ruminococcus lactaris. Most dominant species of the order Bacteroidales were positively associated with fecal concentrations of either acetic, isovaleric, or isobutyric acid, the latter being negatively correlated with blood levels of triglycerides. The relative sequence abundance of one Gemmiger species (Ruminococcaceae) and of Coprococcus comes (Lachnospiraceae) correlated positively with blood levels of LDL cholesterol and triglycerides, respectively. CONCLUSION: Flaxseeds increase enterolignan production but do not markedly alter fecal metabolome and dominant bacterial communities. The data underline the possible role of members of the family Ruminococcaceae in the regulation of enterolignan production and blood lipids.
SCOPE: Flaxseeds contain the phytoestrogens lignans that must be activated to enterolignans by intestinal bacteria. We investigated the impact of flaxseeds on fecal bacterial communities and their associations with fecal and blood metabolites. METHODS AND RESULTS: Nine healthy male adult subjects ingested 0.3 g/kg/day flaxseeds during 1 week. Gut bacteria as well as blood and fecal metabolites were analyzed. Ingestion of flaxseeds triggered a significant increase in the blood concentration of enterolignans, accompanied by fecal excretion of propionate and glycerol. Overall diversity and composition of dominant fecal bacteria remained individual specific throughout the study. Enterolactone production was linked to the abundance of two molecular species identified as Ruminococcus bromii and Ruminococcus lactaris. Most dominant species of the order Bacteroidales were positively associated with fecal concentrations of either acetic, isovaleric, or isobutyric acid, the latter being negatively correlated with blood levels of triglycerides. The relative sequence abundance of one Gemmiger species (Ruminococcaceae) and of Coprococcus comes (Lachnospiraceae) correlated positively with blood levels of LDL cholesterol and triglycerides, respectively. CONCLUSION: Flaxseeds increase enterolignan production but do not markedly alter fecal metabolome and dominant bacterial communities. The data underline the possible role of members of the family Ruminococcaceae in the regulation of enterolignan production and blood lipids.
Authors: Johanna W Lampe; Eunji Kim; Lisa Levy; Laurie A Davidson; Jennifer S Goldsby; Fayth L Miles; Sandi L Navarro; Timothy W Randolph; Ni Zhao; Ivan Ivanov; Andrew M Kaz; Christopher Damman; David M Hockenbery; Meredith A J Hullar; Robert S Chapkin Journal: Am J Clin Nutr Date: 2019-08-01 Impact factor: 7.045
Authors: Rachel Mak'Anyengo; Peter Duewell; Cornelia Reichl; Christine Hörth; Hans-Anton Lehr; Sandra Fischer; Thomas Clavel; Gerald Denk; Simon Hohenester; Sebastian Kobold; Stefan Endres; Max Schnurr; Christian Bauer Journal: JCI Insight Date: 2018-03-08
Authors: Ilias Lagkouvardos; Rüdiger Pukall; Birte Abt; Bärbel U Foesel; Jan P Meier-Kolthoff; Neeraj Kumar; Anne Bresciani; Inés Martínez; Sarah Just; Caroline Ziegler; Sandrine Brugiroux; Debora Garzetti; Mareike Wenning; Thi P N Bui; Jun Wang; Floor Hugenholtz; Caroline M Plugge; Daniel A Peterson; Mathias W Hornef; John F Baines; Hauke Smidt; Jens Walter; Karsten Kristiansen; Henrik B Nielsen; Dirk Haller; Jörg Overmann; Bärbel Stecher; Thomas Clavel Journal: Nat Microbiol Date: 2016-08-08 Impact factor: 17.745
Authors: Jonas Zantow; Sarah Just; Ilias Lagkouvardos; Sigrid Kisling; Stefan Dübel; Patricia Lepage; Thomas Clavel; Michael Hust Journal: Sci Rep Date: 2016-10-05 Impact factor: 4.379